D.E. Shaw & Co
XBIT icon

D.E. Shaw & Co’s XBiotech XBIT Stock Holding History

D.E. Shaw & Co’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,052
Closed -$52.8K – 4920
2022
Q4 		$52.8K Sell
15,052
-33,097
-69% -$113K ﹤0.01% 4434
2022
Q3 		$175K Buy
48,149
+12,819
+36% +$60.3K ﹤0.01% 4504
2022
Q2 		$199K Buy
+35,330
New +$238K ﹤0.01% 4556
2022
Q1 		– Sell
-11,042
Closed -$123K – 5989
2021
Q4 		$123K Sell
11,042
-5,240
-32% -$68.2K ﹤0.01% 5021
2021
Q3 		$211K Sell
16,282
-4,647
-22% -$74K ﹤0.01% 4543
2021
Q2 		$347K Buy
20,929
+3,507
+20% +$59.5K ﹤0.01% 4201
2021
Q1 		$299K Buy
+17,422
New +$325K ﹤0.01% 3705
2020
Q2 		– Sell
-28,105
Closed -$298K – 4286
2020
Q1 		$298K Sell
28,105
-147,684
-84% -$2.4M ﹤0.01% 3472
2019
Q4 		$3.28M Buy
+175,789
New +$2.26M ﹤0.01% 2072

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.E. Shaw & Co's XBIT Position: Q1 2023 in Review

D.E. Shaw & Co sold out of XBiotech (XBIT) in Q1 2023, closing a stake of 15,052 shares — an estimated $52.8K sold.

D.E. Shaw & Co first reported a position in XBIT in Q4 2019 and held it in 9 quarters. The position peaked at $3.28M in Q4 2019. 38 funds tracked by Wall St. Rank hold XBIT as of Q1 2023.

  • D.E. Shaw & Co reported no remaining XBiotech position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 15,052 XBiotech shares in Q1 2023, an estimated $52.8K.
  • D.E. Shaw & Co first reported a position in XBiotech in Q4 2019 and held it in 9 quarters.
  • D.E. Shaw & Co's XBiotech position peaked at $3.28M in Q4 2019.
  • 38 funds tracked by Wall St. Rank held XBiotech as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.